An effective, safe and cost-effective cell-based chimeric vaccine against SARS-CoV2
z. Cheng, D. Zhang, X. Liu…·Y. Wang
This study develops a cell-based chimeric vaccine against SARS-CoV-2 that induces strong T cell immunity and neutralizing antibodies without toxicity.